Catalyst Capital Advisors’s Equillium EQ Stock Holding History

Catalyst Capital Advisors’s Portfolio EQ Stock Details EQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-480	Closed	-$4K	–	415
2018 Q4	$4K	Buy	+480	New	+$6.67K	﹤0.01%	380

Other funds holding EQ

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Catalyst Capital Advisors's EQ Position: Q1 2019 in Review

Catalyst Capital Advisors sold out of Equillium (EQ) in Q1 2019, closing a stake of 480 shares — an estimated $4K sold.

Catalyst Capital Advisors first reported a position in EQ in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 31 funds tracked by Wall St. Rank hold EQ as of Q1 2019.

Catalyst Capital Advisors reported no remaining Equillium position as of Q1 2019 after selling out during the quarter.
Catalyst Capital Advisors sold 480 Equillium shares in Q1 2019, an estimated $4K.
Catalyst Capital Advisors first reported a position in Equillium in Q4 2018 and held it in 1 quarter.
Catalyst Capital Advisors's Equillium position peaked at $4K in Q4 2018.
31 funds tracked by Wall St. Rank held Equillium as of Q1 2019.

Based on Catalyst Capital Advisors's 13F filing for Q1 2019, filed 8 May 2019.